𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term follow-up of insulin-dependent diabetes mellitus patients with recurrent episodes of severe hypoglycaemia

✍ Scribed by P. Oskarsson; U. Adamson; N. Clausen Sjöbom; P.-E. Lins

Book ID
117371615
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
158 KB
Volume
44
Category
Article
ISSN
0168-8227

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cumulative cognitive impairment followin
Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus
✍ S. J. Langan; I. J. Deary; D. A. Hepburn; B. M. Frier 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 876 KB

To examine the hypothesis that episodes of severe hypogtycaemia may cause cumulative cognitive impairment, 100 Type 1 (insulin-dependent) diabetic patients were examined. Their age range was 25-52 years, and the onset of diabetes had occurred after the age of 19 years. Patients with evidence of orga

A Structural Equation Model for Predicto
A Structural Equation Model for Predictors of Severe Hypoglycaemia in Patients with Insulin-dependent Diabetes Mellitus
✍ Gold, A.E.; Frier, B.M.; MacLeod, K.M.; Deary, I.J. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

There are several predictors of severe hypoglycaemia in patients with insulin-dependent diabetes mellitus (IDDM), many of which are correlated. To assess factors which may be predictive of severe hypoglycaemia, structural equation modelling was used to test specific hypotheses using prospective data

Follow-up of cyclosporin A treatment in
Follow-up of cyclosporin A treatment in Type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects
✍ S. Martin; G. Schernthaner; J. Nerup; F. A. Gries; V. A. Koivisto; J. Dupré; E. 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 541 KB

In the Canadian/European randomized controlled study on cyclosporin A (CsA) in recent onset Type 1 (insulin-dependent) diabetes, treatment with the immunosuppressive drug had increased and maintained Beta-cell function and clinical remission during the first 12 months. Following discontinuation of t